sn 23862 has been researched along with dicumarol in 1 studies
Studies (sn 23862) | Trials (sn 23862) | Recent Studies (post-2010) (sn 23862) | Studies (dicumarol) | Trials (dicumarol) | Recent Studies (post-2010) (dicumarol) |
---|---|---|---|---|---|
20 | 0 | 4 | 2,260 | 33 | 110 |
Protein | Taxonomy | sn 23862 (IC50) | dicumarol (IC50) |
---|---|---|---|
Cholinesterase | Homo sapiens (human) | 0.0026 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.3 | |
NAD | Homo sapiens (human) | 0.2585 | |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | 4.426 | |
Proprotein convertase subtilisin/kexin type 7 | Homo sapiens (human) | 1.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denny, WA; Johansson, E; Neidle, S; Parkinson, GN | 1 |
1 other study(ies) available for sn 23862 and dicumarol
Article | Year |
---|---|
Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
Topics: Aniline Mustard; Aziridines; Benzamides; Binding Sites; Crystallography, X-Ray; Dicumarol; Drug Design; Enzyme Activation; Enzyme Inhibitors; Escherichia coli; Flavin Mononucleotide; Models, Molecular; Nitroreductases; Oxidation-Reduction; Prodrugs; Protein Binding | 2003 |